Jim Jogerst

Jim Jogerst currently serves as the Chief Business Officer at ADC Therapeutics, a position held since 2023. Previously, Jim held the Chief Business Officer role at Rubius Therapeutics and served as Senior Director of Business Development at The Janssen Pharmaceutical Companies of Johnson & Johnson, where responsibilities included overseeing corporate development strategy and managing business development, licensing, and M&A processes. Jim's experience also encompasses leadership roles at BERG Health, Adare Pharmaceuticals, and Alcon, contributing to corporate development and strategic initiatives. Academic credentials include an M.B.A. in Finance and International Business from Pepperdine Graziadio Business School and additional MBA qualifications from EBS Universität für Wirtschaft und Recht, along with a Bachelor's Degree in Economics and Political Science from the University of North Texas.